Precision Oncology: Interview with Presage Biosciences Founder Dr. James Olson
As the costs of sequencing and drug testing continue to be driven down, we’ll increasingly see technologies that take into account differences between people and even within people. The hope is that this will lead to ultra-personalized medicine...
Source: Medgadget - Category: Technology Consultants Authors: Shiv Gaglani Tags: Medgadget Exclusive Oncology Source Type: blogs
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Child Development | Children | Clinical Trials | Learning | Lymphoma | Pediatrics | Prednisolone | Prednisone | Rituxan | Skin | Study | Technology Consultants | Toxicology | Universities & Medical Training